Biomedical Proteomics

the Biomedical Proteomics group aims to develop robust proteomics pipelines for the phenotyping of patients through in-depth characterization of biofluid proteomes, the identification of new biomarkers and the improved comprehension of pathogenetic mechanisms. 

Projects

Integrative Omics

Integrative omics to study gene expression regulation Gene expression is regulated in part by the incorporation of histone variants and by the […]

Read More

Plasma Biomarkers

Plasma biomarkers MS-based proteomics is particularly well-suited for identifying specifically and measuring accurately the abundance of protein biomarker candidates. During the last […]

Read More